These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4441832)

  • 21. Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives.
    Bergstein NA
    Acta Obstet Gynecol Scand Suppl; 1976; 54():51-9. PubMed ID: 788446
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
    Lawson JS; Yuliano SE; Pasquale SA; Osterman JJ
    Am J Obstet Gynecol; 1979 Jun; 134(3):315-20. PubMed ID: 377968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical use of combined contraceptive preparations of Hungarian manufacture].
    Farkas M
    Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open assessment of a new low dose oestrogen combined oral contraceptive.
    Hughes I
    J Int Med Res; 1978; 6(1):41-5. PubMed ID: 627304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three and one-half years' experience with a lower-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB; Korba VD
    Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J
    J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Low dose p-pills, Gynatrol and Mikrogyn].
    Falck Larsen J
    Ugeskr Laeger; 1976 Sep; 138(40):2446-7. PubMed ID: 969002
    [No Abstract]   [Full Text] [Related]  

  • 33. Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.
    Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():43-8. PubMed ID: 393049
    [No Abstract]   [Full Text] [Related]  

  • 34. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB
    J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An incremental-dose combined oestrogen-progestogen oral contraceptive: cycle control and endometrial changes.
    Khoo SK; McKenna H
    Aust N Z J Obstet Gynaecol; 1980 Aug; 20(3):168-71. PubMed ID: 6936018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel-ethinyl estradiol ratios.
    Arnt IC; Ferrari A; Sartoretto JN; Woutersz TB
    Fertil Steril; 1977 May; 28(5):549-53. PubMed ID: 323074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of triphasic Tri-Regol tablet in women of borderline age.
    Takács G
    Ther Hung; 1991; 39(4):188-91. PubMed ID: 1811332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of biphasic cyclic hormone therapy in functional bleeding disorders of adolescents (Anteovin).
    Kis-Csitári I
    Ther Hung; 1988; 36(2):73-6. PubMed ID: 3201389
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic usefulness of anteovin.
    Menyhárt K
    Ther Hung; 1989; 37(3):168-71. PubMed ID: 2588200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.